Kuros Biosciences Ltd. announced that Dr. Virginia Jamieson has been appointed Chief Medical Officer and member of the Executive Board with immediate effect. Dr. Jamieson has spent over 25 years in the pharmaceutical industry and has considerable experience in early and late stage clinical development, product registration and medical affairs. Dr. Jamieson already worked for Kuros from 2005 to 2012 as Medical Director and then as Chief Medical Officer and is therefore very familiar with Kuros' products.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.88 CHF | -2.48% | +11.19% | +127.79% |
Apr. 24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
Apr. 17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+127.79% | 330M | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.23% | 22.28B | |
-5.61% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- KURN Stock
- News Kuros Biosciences AG
- Kuros Biosciences Ltd. Appoints Virginia Jamieson as Chief Medical Officer and Member of the Executive Board